Clinical Breast Cancer投稿须知

期刊简介

《Clinical Breast Cancer》是由Elsevier出版社于2000年创办的英文国际期刊（ISSN: 1526-8209，E-ISSN: 1938-0666），该期刊长期致力于肿瘤学领域的创新研究，主要研究方向为医学-肿瘤学。作为SCIE收录期刊（JCR分区 Q2，中科院 3区），本刊采用OA未开放获取模式（OA占比0.1457...%），以发表肿瘤学领域等方向的原创性研究为核心（研究类文章占比80.00%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在140篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Clinical Breast Cancer审稿周期约为约3月。该刊近年未被列入国际预警名单，年发文量约140篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
140 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	ONCOLOGY 肿瘤学 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 3区	ONCOLOGY 肿瘤学 4区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	151 / 322	53.3%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q2	161 / 322	50.16%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：5.4

SJR：0.942

SNIP：0.844

学科类别	分区	排名	百分位
大类：Medicine 小类：Oncology	Q2	151 / 404	62%
大类：Medicine 小类：Cancer Research	Q3	125 / 230	45%

期刊发文

Circ_ 0001667 Promotes Adriamycin Resistance and Malignant Progression via Targeting the miR-193a-5p/Rap2A Molecular Axis in Breast Cancer
Author: Xu, Shilin; Luo, Wen; Li, Mengxin; Li, Quanchao; Hong, Wanxin; Gao, Yun; Yang, Jin; Song, Hongchang; Chen, Li; Yang, Yuanxia; Yang, Chao

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 1, pp. 71-83. DOI: 10.1016/j.clbc.2022.09.008
ABSDELL Model: Development and Internal Validation of a Risk Prediction Model of LVEF Decline in Breast Cancer Patients Treated With Trastuzumab
Author: Liu, Xin; Tao, Liyuan; Wang, Mopei; Li, Haiyan; Xu, Weixian

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 1, pp. 23-31. DOI: 10.1016/j.clbc.2022.10.010
Serratus Plane Block in Breast Cancer Surgery: A Systematic Review and Meta-Analysis
Author: Li, Zhen-Hao; Hong, Wei-Jin; Guo, Xiao-Liang; Li, Xin-Rui; Jiang, Xuan-Yu; Jiang, Yu; Luo, Sheng-Kang

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 1, pp. E1-E13. DOI: 10.1016/j.clbc.2022.10.009
Downregulated miR-367-3p, miR-548aq-5p, and miR-4710 in Human Whole Blood: Potential Biomarkers for Breast Cancer With Axillary Lymph Node Metastasis
Author: Yang, Bin; Wang, Ya-Wen; Qian, Lin-Hui; Xu, Yao; Chen, Xu; Chen, Yan-Duo; Liu, Can; Tian, Ya-Ru; Zhang, Kai

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 2, pp. 189-198. DOI: 10.1016/j.clbc.2022.11.011
Circ_0001777 Affects Triple-negative Breast Cancer Progression Through the miR-95-3p/AKAP12 Axis
Author: Chen, Zhuorong; Gong, Xumeng; Cheng, Chun; Fu, Yinghui; Wu, Wanming; Luo, Zhihui

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 2, pp. 143-154. DOI: 10.1016/j.clbc.2022.11.004
Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database
Author: Zhou, Hong-Lu; Chen, Dan -Dan

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 3, pp. E85-E94. DOI: 10.1016/j.clbc.2023.01.002
In vitro Anti-malignant Property of PCMT1 Silencing and Identification of the SNHG16/miR-195/PCMT1 Regulatory Axis in Breast Cancer Cells
Author: Zhang, Zhongji; Li, Fengbo; Li, Yan; Li, Zhong; Jia, Guangwei

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 3, pp. 302-316. DOI: 10.1016/j.clbc.2022.12.013
Circ_ 0108942 Regulates the Progression of Breast Cancer by Regulating the MiR-1178-3p/TMED3 Axis
Author: Yang, Chuansheng; Wang, Meijiao; Huang, Renfeng; Ou, Linyang; Li, Min; Wu, Wanming; Lei, Ruiwen

Journal: CLINICAL BREAST CANCER. 2023; Vol. 23, Issue 3, pp. 291-301. DOI: 10.1016/j.clbc.2022.12.014

Clinical Breast Cancer

临床乳腺癌

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询